X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
analysis (1) 1
atr (1) 1
cancer (1) 1
care and treatment (1) 1
cell death (1) 1
cells (1) 1
chemotherapy (1) 1
cisplatin (1) 1
crosslink (1) 1
crosslink - cul4 - fanconi anemia (1) 1
crosslinked polymers (1) 1
cul4 (1) 1
damage (1) 1
dna (1) 1
dna replication (1) 1
fancd2 (1) 1
fanconi anemia (1) 1
fanconi's anemia (1) 1
index medicus (1) 1
interstrand cross-links (1) 1
ligases (1) 1
mitomycin (1) 1
molecular-basis (1) 1
nedd8-activating enzyme (1) 1
nucleases (1) 1
oncology (1) 1
research (1) 1
rna (1) 1
s-phase (1) 1
ssdna (1) 1
target (1) 1
ubiquitin (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC CANCER, ISSN 1471-2407, 11/2019, Volume 19, Issue 1, pp. 1 - 16
Background DNA-crosslinking agents like cisplatin and mitomycin C (MMC) are indispensible for the treatment of many solid malignancies. These anticancer drugs... 
TARGET | CELLS | Fanconi anemia | CUL4 | CANCER | Cisplatin | DAMAGE | Chemotherapy | ONCOLOGY | FANCD2 | S-PHASE | INTERSTRAND CROSS-LINKS | NEDD8-ACTIVATING ENZYME | Crosslink | MOLECULAR-BASIS | ssDNA | ATR | Ubiquitin | Nucleases | DNA replication | Care and treatment | Mitomycin | RNA | Research | Fanconi's anemia | Crosslinked polymers | Ligases | Cell death | Analysis | DNA | Cancer | Crosslink - CUL4 - Fanconi anemia
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.